LEO Pharma will acquire the global product rights, except for Afghanistan and Pakistan, and take over the sales and marketing teams in 14 countries, as well as Bayer’s Italian factory in Segrate.

DEBRA Research GmbH, a non-profit organization dedicated to advancing research, advocacy, and support for those affected by epidermolysis bullosa (EB) and LEO Pharma, a global leader in medical ...

(RTTNews) - Gilead Sciences, Inc. (GILD) and LEO Pharma entered strategic partnership to develop and commercialize LEO Pharma's small molecule oral STAT6 (signal transducer and activator of ...

(TopAlliance Biosciences), announced a distribution and marketing partnership with LEO Pharma for toripalimab in Europe. This collaboration aims to promote the accessibility of toripalimab in ...